FDA novel drug approvals 2026 include dental-relevant agents

The FDA has released its list of novel drug approvals for 2026, which may include new antibiotics, antivirals, and local anesthetics with potential dental applications. While primarily for the US market, these approvals often influence Indian regulatory decisions and clinical guidelines. BDS graduates should note any new antimicrobials or pain management drugs that could later become available in India.